Alternatives to Veradigm Real-World Evidence

At Komodo Health, we integrate an extensive understanding of patient interactions with cutting-edge algorithms and years of clinical knowledge to create our Healthcare Map, which offers the most accurate representation of the U.S. healthcare landscape. This Healthcare Map serves as the backbone for our comprehensive suite of software solutions, designed to help you provide exceptional value to your customers, colleagues, and patients alike. Relying solely on traditional scholarly data for strategic planning is now outdated. Our Aperture platform has been meticulously crafted to deliver unparalleled insights into clinical leadership and influence, enabling improvements in care standards where they are needed most—whether that involves the most referenced author, a prominent social media influencer, or the physician with the highest patient volume. Moreover, conventional open/sampled prescription and patient-level data often overlook critical patterns that are essential for accurately identifying individuals with complex care needs or uncommon medical conditions. By addressing these gaps, we aim to enhance patient outcomes and streamline healthcare delivery.

Numerous organizations globally rely on IQVIA to accelerate the drug development process, guarantee the safety and quality of products, enhance commercial efficacy, deliver appropriate treatments to patients, and ultimately promote improved health outcomes by facilitating access to and delivery of healthcare. Transform your approach to clinical development by seamlessly integrating data, technology, and analytics to streamline your trials. The outcome? Quicker decision-making and minimized risks, enabling you to provide transformative therapies at a faster pace. With its expertise rooted in data, sophisticated analytics, and deep industry knowledge, IQVIA offers tailored capabilities to clients throughout the healthcare landscape. Stay informed by exploring the latest insights and updates from IQVIA's data scientists, healthcare professionals, researchers, and other industry experts on crucial topics that resonate with your interests. From emerging industry developments to practical applications of our capabilities, a wealth of information awaits you here. Engaging with this content also empowers you to stay ahead in a rapidly evolving healthcare environment.

Flatiron Health's Evidence Solutions provide a versatile method for generating real-world evidence, both prospective and retrospective, which aids life sciences companies in efficiently meeting their oncology research objectives. At the heart of these offerings is Flatiron Horizon, a comprehensive platform that combines a rich database of more than 5 million anonymized patient records and 1.5 billion data points, coupled with advanced curation techniques and disease-specific machine learning models. This innovative platform is designed to facilitate various phases of the biopharma lifecycle, including discovery, clinical study design, regulatory submissions, and post-marketing commitments. Furthermore, Flatiron's services deliver customized real-world data configurations that cater specifically to oncology, enabling prospective evidence generation through minimally invasive studies and optimizing protocols for better patient identification. Additionally, the platform ensures a streamlined transfer of data from electronic health records to electronic data capture systems with the functionality of Flatiron Clinical Pipe, enhancing overall research efficiency and effectiveness. Such capabilities position Flatiron Health as a leader in transforming oncology research through the power of real-world data.

Verana Health operates as a platform for real-world data that converts both structured and unstructured information from electronic health records into curated, de-identified, disease-focused data modules through its clinician-informed and AI-enhanced VeraQ population health data engine. By aggregating data from key collaborations with prominent medical registries, including the American Academies of Ophthalmology, Neurology, and Urological Association, the platform integrates insights from over 20,000 clinicians and approximately 90 million patient records, thereby supplying high-quality datasets in near real-time for the purposes of generating real-world evidence, identifying clinical trial sites and subjects, reporting clinician quality, and managing medical registries. Users can access this wealth of information through cloud services like AWS Data Exchange and Amazon Redshift, which provide self-service API access, a user-friendly dashboard, and tools for customizable cohort discovery. Furthermore, the system employs advanced AI and machine learning algorithms along with comprehensive data quality assessments to ensure the reliability and accuracy of the information provided. This innovative approach not only facilitates efficient data utilization but also enhances the overall quality of healthcare research and practice.

Genoox is revolutionizing the field of genomics through its dynamic and expanding community, which enables the accumulation of the most pertinent database and facilitates the delivery of actionable, real-world genomic insights that significantly affect lives, enhance clinical outcomes, and influence healthcare business practices. By harnessing community power, Genoox merges public data with community-generated information to optimize the journey from DNA sample to clinical report, thereby improving patient care through the accessibility and applicability of genomic data at critical moments. The company's innovative solutions are transforming the landscape of genomics, while also supporting research and life sciences enterprises with an insightful platform that leverages real-world data and evidence, bolstered by comprehensive genomic analytics, which assists researchers in simplifying intricate genomic information and achieving meaningful breakthroughs with cutting-edge genetic tools. Moreover, Genoox collaborates with biosystems firms like DNA sequencing companies to integrate its advanced genomic engine with specialized assays, further enhancing the capabilities of the entire genomics ecosystem. Ultimately, Genoox stands at the forefront of genomic innovation, consistently aiming to empower healthcare professionals and researchers alike.

The advanced features of the Inovalon ONE® Platform enable our clients and collaborators to thrive by utilizing extensive industry connections, vast primary-source real-world data, advanced analytics, and robust cloud-based technologies to enhance healthcare outcomes and economics. Central to modern healthcare is the necessity to consolidate and scrutinize vast amounts of varied data, extract valuable insights from these analyses, and apply this knowledge to effect significant improvements in patient outcomes, operational performance, and healthcare economics. With analytics and capabilities employed by over 20,000 clients, we draw upon the primary source data from more than 69.5 billion medical events, encompassing one million healthcare professionals, 611,000 clinical environments, and 350 million distinct patients. This extensive network of data and analytics is crucial for driving innovation and efficiency in the healthcare sector, fostering an environment where informed decisions lead to substantial advancements.

Truveta operates as a health data and analytics platform focused on leveraging information to enhance patient lives. By consolidating de-identified electronic health records from more than 30 healthcare systems, it provides researchers with access to a rich array of patient data, which includes clinical notes, imaging, and genomic information. This vast repository represents data from upwards of 120 million patients, giving a well-rounded perspective on healthcare delivery throughout the United States. The Truveta Studio, which serves as the platform's analytics hub, equips researchers with sophisticated tools like notebooks and dashboards, all maintained within a secure and HIPAA-compliant framework. With daily updates to its data, the platform guarantees that insights into patient care and outcomes are both current and relevant. Furthermore, Truveta's dedication to data integrity is showcased by its implementation of the Truveta Language Model, an advanced AI framework that efficiently translates EHR data into precise and reliable data points for the advancement of medical research. This commitment not only enhances research capabilities but also fosters a deeper understanding of healthcare trends and patient needs, ultimately contributing to improved health outcomes.

ConcertAI stands out as a prominent provider of AI-driven solutions within the healthcare sector, particularly in the field of oncology. Their core mission revolves around enhancing patient outcomes and expediting insights by leveraging top-tier real-world data, cutting-edge AI technologies, and deep scientific knowledge. The company presents an array of products and services aimed at improving both clinical research and patient care experiences. Their Real-World Data Products deliver extensive, customized datasets that cater to diverse research needs across various enterprises. By simplifying clinical trial processes, their digital trial solution ensures efficiency, while the Clinical Trial Optimization (CTO) platform employs extensive AI capabilities to refine the design and implementation of trials specifically in oncology and hematology. Additionally, in partnership with NeoGenomics, ConcertAI has introduced CTO-H, a software-as-a-service (SaaS) solution that concentrates on hematological malignancies, providing sophisticated research analytics and optimizing operational workflows. This integration of advanced technologies not only enhances research capabilities but also significantly contributes to the advancement of patient care in complex medical fields.

Cytel stands out as a prominent global innovator in software for clinical trial design, biometrics, and advanced analytics, focusing on maximizing the efficiency of clinical trials while aiding pharmaceutical companies in harnessing the full scope of both clinical and real-world data. Established in 1987 by renowned statisticians Cyrus Mehta and Nitin Patel, Cytel has consistently been a leader in adaptive clinical trial technology and the field of biostatistics. Its software solutions, notably the East Horizon platform, facilitate accurate trial design and simulation, employing adaptive and Bayesian methodologies to enhance protocols and expedite the drug development process. The East Horizon platform serves as a comprehensive integration of Cytel's reliable software offerings, featuring R integration that significantly improves trial design functions. Furthermore, Cytel provides the Xact software suite, which is an all-encompassing toolkit designed for statistical analysis of small datasets, including those with sparse and missing data. By continuously innovating and expanding its product offerings, Cytel remains committed to providing cutting-edge solutions that meet the evolving needs of clinical research.

Combine and liberate your disorganized health information through an interactive AI and NLP solution that provides valuable health insights for various stakeholders. This innovative technology serves Providers by hastening the data abstraction process and ensuring the clinical information validation found within notes, thus minimizing the time and costs associated with identifying care gaps, assessing the quality of care through dashboards, and producing registry reports. For Payers, it facilitates the integration and analysis of claims alongside clinical notes, enhancing the management of high-risk and high-cost member populations. In the realm of Life Sciences, this solution enables swift patient matching to clinical trials using databases alongside clinical note data, maximizing the potential of real-world clinical evidence. Ember offers a comprehensive approach that merges NLP with predictive analytics, streamlining healthcare analytics for unstructured data to boost quality, efficiency, and outcomes in the healthcare system. As a result, stakeholders can make informed decisions that lead to improved patient care and resource allocation.

Offering a robust, cloud-centric platform, comprehensive longitudinal electronic health record (EHR) data, and advanced analytical tools, this system assists healthcare providers and life sciences organizations in discovering new relationships among previously isolated healthcare information. It comprises a suite of software-as-a-service (SaaS) applications that facilitate swift population management, performance evaluation, and meaningful engagement with both patients and providers. This solution allows healthcare organizations to gather, link, and merge information from numerous varied sources across their entire enterprise and clinically integrated networks. It empowers designers of care and quality programs to effectively search and explore populations related to diagnoses, treatments, outcomes, costs, and demographics. Furthermore, it swiftly pinpoints target populations, enabling improved decision-making regarding risk-stratified care management. Additionally, it presents an integrated framework that correlates vast amounts of clinical, operational, and financial events into benchmarks and scorecards for insightful comparisons, ultimately enhancing the overall quality of care delivered. This comprehensive approach not only streamlines data integration but also supports innovative healthcare solutions.

By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.

Plexus is an innovative platform that utilizes AI to analyze healthcare data, aiming to enhance the targeting of healthcare providers and map clinical networks effectively. By harnessing insights from over a billion data points, the software skillfully identifies and profiles key clinicians in various therapeutic fields. It bolsters engagement efforts through precision segmentation driven by predictive analytics, enabling pharmaceutical companies to focus on healthcare professionals who significantly influence patient care and the adoption of treatments. The platform also creates detailed clinical network maps at various scales—local, regional, and national—offering a thorough understanding of the relationships between healthcare professionals that aids in the development of personalized marketing, sales, and medical approaches. In addition to this, Plexus integrates a variety of data sources, such as claims data and future prescription estimates, to enhance targeting efforts and optimize resource distribution. By providing valuable insights for marketing, sales, medical teams, and business intelligence divisions, Plexus ultimately empowers organizations to make informed decisions that can drive better patient outcomes. This comprehensive approach ensures that stakeholders have the necessary tools to navigate the complexities of the healthcare landscape effectively.

The Aetion Evidence Platform® provides essential real-world evidence tailored for life sciences companies, payers, and risk-bearing providers. Our mission is to tackle significant healthcare inquiries: identifying the most effective treatments, determining their ideal patient populations, and establishing the optimal timing for their application. This approach directly translates into improved decision-making. Serving as a collaborator to many of the leading 20 global biopharma companies, prominent payers, and the FDA, Aetion plays a pivotal role in shaping the most vital decisions within the industry. Our transparent analytical methods facilitate advancements in product development, commercialization strategies, and payment innovations, steering healthcare into a new age. By transitioning the use of real-world evidence from merely descriptive analytics to deriving causal insights, the Aetion Evidence Platform is at the forefront of this evolution. Furthermore, we provide timely answers within a matter of days or weeks, delivering the swift results necessary to enhance both clinical and financial outcomes. Make the most of your available data by transforming it into actionable insights that can be utilized immediately for better healthcare solutions.

Clinithink stands out as a premier technology firm in the healthcare sector, focusing on artificial intelligence solutions that convert unstructured medical information into valuable insights. The company's proprietary CLiX platform leverages Clinical Natural Language Processing (CNLP) to decipher intricate clinical narratives, which empowers healthcare providers to improve both patient outcomes and operational productivity. Clinithink delivers customized solutions across various domains, including life sciences, revenue cycle management, and population health, effectively tackling issues such as identifying patient cohorts, maximizing reimbursement, and monitoring disease progression. With its cutting-edge technology, Clinithink has earned the confidence of top pharmaceutical and healthcare entities globally, establishing its leadership in the realm of healthcare AI and digital health progress. Moreover, the CLiX platform is adept at comprehending a wide array of unique and intricate clinical concepts, including but not limited to certainty, severity, laterality, and temporality, further enhancing its utility in clinical settings. As the demand for innovative healthcare solutions grows, Clinithink remains committed to advancing its technology to meet the evolving needs of the industry.

At Genospace, we recognize that the evolution of precision medicine is being propelled by advancements in genomics, yet the challenge of effectively scaling its implementation remains unresolved. Our mission is to bridge this gap. Our innovative platform aims to transform biomedical data into valuable insights that are easily accessible for all, particularly for those actively involved in delivering care. Equip your clinicians and researchers with essential information that empowers them to make well-informed choices while participating in our goal of utilizing intricate molecular data to enhance patient outcomes and speed up the processes of drug development and research. In this context, the significance of large-scale population data for drug discovery and research cannot be overstated. Utilize cohort-driven analyses through the Genospace platform to support your research initiatives. We have a strong focus on clinical trial research, enabling the Genospace platform to seamlessly align fragmented patient information with intricate trial requirements, thus facilitating quicker patient recruitment. Furthermore, our platform is designed to integrate genomic medicine into standard clinical care practices, making it easier than ever to harness the power of genomics in everyday healthcare. Together, we can push the boundaries of what’s possible in patient care and research.

Sorcero is an innovative platform powered by artificial intelligence that aims to convert intricate medical data into practical insights for the life sciences sector. It offers a range of products such as Medical Insights Management, Intelligent Publication Monitoring, Plain Language Summaries, and Intelligent Systematic Literature Review, all of which work together to unify and interpret both structured and unstructured data from diverse sources. By leveraging AI to dissect medical themes, notes, and research findings, Sorcero provides clear and high-quality responses to challenging medical inquiries, thereby assisting teams in Medical Affairs, Pharmacovigilance, and Regulatory Affairs in making better-informed choices. The platform enhances rapid literature monitoring, facilitates content creation, and supports evidence-based decision-making, significantly improving patient outcomes while also streamlining operational processes. Additionally, Sorcero's capabilities can lead to a more effective collaboration among various stakeholders within the healthcare ecosystem.

On-demand patient identity resolution is achieved by efficiently mastering and connecting data in real-time. By converting protected health information into universal, de-identified HealthVerity IDs, organizations within the life sciences sector can effectively construct and disseminate the patient journey across various partner datasets, thereby establishing a unified source of truth regarding patient identity. This approach also facilitates internal data sharing among different organizational departments, enhancing the overall understanding of the patient journey. Furthermore, it allows for adaptable external data exchanges with entities such as patient registries, health insurers, and other associated companies. HealthVerity Census serves as an initial step toward developing a data strategy focused on activation, interoperability, and the longitudinal tracking of patient information. Utilizing an advanced PaaS de-identification solution, it empowers the activation of both internal and external data touchpoints, breaking down silos that often isolate critical information within the enterprise. These comprehensive capabilities ultimately contribute to improved patient outcomes and more informed decision-making across the healthcare landscape.

Signals VitroVivo integrates various assay developments, ranging from low throughput to ultra-high-throughput production assays, High Content Screening, and in vivo research, allowing users to access all assay and screening information through a single, comprehensive platform. This system is not only adaptable for individual assay tasks during the development phase, but it is also robust enough to accommodate more complex studies and a wide array of techniques, making it scalable to manage extensive data volumes. Scientists can utilize a consistent and repeatable approach for both data collection and processing protocols, facilitating swift and straightforward structure-activity relationship evaluations for both small and large molecules. Designed to meet specific needs in managing studies, treatments, and samples, this platform enhances the overall efficiency and effectiveness of scientific research, ultimately leading to more innovative discoveries.

Organizations in the life sciences sector, regardless of their size or complexity, depend on the ICyte platform to enhance pharmaceutical market entry and therapy commercialization processes. The ICyte platform equips biotech and pharmaceutical manufacturers with exceptional services that include the aggregation of channel and patient data, management of contracts and pricing, gross-to-net forecasting, and accrual systems, as well as expert solutions for launch and pricing transparency. By utilizing ICyte, both pharmaceutical and biotech firms can significantly enhance their market access capabilities by swiftly converting patient, payer, complex transaction, and channel data into practical insights. Additionally, ICyte offers analytics-as-a-service, facilitating the deployment of standardized models and metrics as a unified service across various applications, data streams, and analytical uses. The platform integrates key performance indicators (KPIs) tailored specifically for life sciences organizations. Furthermore, it features advanced analytics tools, including forecasting, scenario modeling, and a recommendation engine powered by machine learning, which aid companies in making data-driven decisions. Ultimately, ICyte is positioned as a comprehensive solution that not only simplifies processes but also empowers organizations to navigate the complexities of the pharmaceutical landscape effectively.

Enhance your scientific research and equip your R&D team with unified data in the cloud. The Tetra R&D Data Cloud merges the only cloud-native data platform specifically designed for global pharmaceutical enterprises with the expansive and rapidly growing network of Life Sciences integrations and extensive industry expertise, providing a robust solution for leveraging your most critical asset: R&D data. This platform encompasses the entire life-cycle of your R&D data, facilitating processes from acquisition to harmonization, engineering, and subsequent analysis while offering native compatibility with cutting-edge data science tools. It supports a vendor-agnostic approach with pre-existing integrations that allow seamless connectivity to instruments, analytics and informatics applications, as well as ELN/LIMS and CRO/CDMOs. By consolidating data acquisition, management, harmonization, integration/engineering, and data science enablement into one comprehensive platform, it simplifies the complexities of R&D operations. This holistic approach not only streamlines workflows but also unlocks new possibilities for innovation and discovery.

SteepRock offers a comprehensive suite of AI-driven tools aimed at enhancing your market presence through the identification of key influencers and the analysis of extensive datasets, while also streamlining analytics processes, revealing concealed insights, and condensing multimedia content to promote more effective decision-making. Our premier offering, Opinion Leader Analytics (OLA), functions as an innovative healthcare big data search engine that delivers in-depth insights into healthcare professionals (HCPs), healthcare organizations (HCOs), care systems, payers, conferences, and digital/social media landscapes. Additionally, the Opinion Leader Management System (OLMS) provides a holistic perspective on pivotal individuals, patient and professional organizations, and accounts that influence your brand by aggregating real-time information on billions of external activities alongside your company’s internal operations. With our AI analytics platform, raw data is transformed into clear, actionable strategies that strip away personal biases and subjective inclinations, thereby enabling you to make precise, objective, and impactful decisions. This powerful combination of tools not only enhances your understanding of the market but also equips you with the necessary insights to stay ahead of the competition.

Harnessing actionable insights from the leading AI-driven clinical analytics platform allows your teams to effectively manage risk and enhance performance throughout studies, systems, sites, and vendor relationships. The cutting-edge technology from Saama is specifically crafted to optimize workflows, automate labor-intensive tasks, and foster improved collaboration among various clinical functions such as operations, medical review, data management, biostatistics, and pharmacovigilance. Both sponsors and CROs depend on Saama's capabilities for data aggregation and AI solutions, which facilitate superior decision-making, minimize delays, and drastically reduce costs and timelines associated with drug development. By leveraging Saama's tools, you can accelerate the pace of clinical trial innovation. When your clinical data is centralized and continuously updated, it simplifies the lives of your ClinOps and medical review teams considerably. Furthermore, Data Managers, often undervalued, can shift their focus from repetitive tasks to the critical data points that truly drive project success, ensuring that their expertise is fully utilized in the process. This transformation not only enhances efficiency but also contributes to the overall quality of clinical outcomes.

Pantheon is an innovative software platform powered by artificial intelligence that focuses on identifying, profiling, engaging, and mapping healthcare professionals and Key Opinion Leaders (KOLs). By leveraging sophisticated analytics, it extracts valuable information from diverse sources, including conference presentations, publications, clinical trial activities, and social media, to create detailed profiles of prominent individuals in the healthcare sector. This platform assists users in fostering relationships with these influential leaders by streamlining their engagement efforts, which helps in tracking interactions and activities effectively. It also provides tools such as sentiment analysis, tailored reporting, and compatibility with CRM systems, facilitating smooth coordination among various teams. Primarily aiding the pharmaceutical and healthcare industries, Pantheon enhances collaboration with thought leaders for purposes like clinical trials, sales, marketing, and product innovation. Moreover, the platform is designed to be customizable and adheres to industry regulations, ensuring it meets the specific needs of its users. With its extensive features, Pantheon empowers organizations to strategically engage with key figures in healthcare, ultimately driving better outcomes in their initiatives.

Efficiently merge the multiomic information of patients with their health records to provide more tailored care solutions. Implement specialized data repositories to facilitate extensive analyses and foster collaborative research initiatives on a population-wide scale. Expedite research processes by leveraging adaptable workflows and comprehensive computational tools. Ensure the safeguarding of patient privacy through adherence to HIPAA standards, complete with robust data access and logging mechanisms. AWS HealthOmics empowers healthcare and life science organizations, along with their software collaborators, to securely store, retrieve, and analyze diverse omics data, such as genomic and transcriptomic information, ultimately yielding valuable insights that enhance health outcomes and propel scientific advancements. Manage and evaluate omics data for extensive patient cohorts to discern how variations in omics relate to phenotypic expressions within the population. Develop consistent and accountable clinical multiomics workflows designed to minimize turnaround times while boosting efficiency. Seamlessly incorporate multiomic assessments into clinical trials aimed at evaluating new therapeutic candidates, thereby enhancing the overall drug development process. By harnessing these innovative approaches, organizations can ensure a deeper understanding of patient health and contribute to groundbreaking research findings.

Aktana leverages advanced artificial intelligence enhanced by real-time human insights to equip sales and marketing teams in the life sciences sector with vital information that enriches the customer experience. Their AI-driven platform for next-best-action seamlessly integrates with various data sources and key components of your commercial technology stack, converting vast amounts of information into actionable recommendations that fit within established workflows. By infusing intelligence into the entire omnichannel framework, Aktana ensures that every customer interaction resembles an ongoing dialogue—smooth, timely, and relevant. Currently, more than half of the leading 20 global pharmaceutical companies utilize Aktana’s Contextual Intelligence Engine, which is designed to streamline and enhance personalized omnichannel engagements on a large scale. In fact, over 300 brands worldwide are actively using Aktana, highlighting its significance in fostering intelligent customer interactions across the life sciences industry. This widespread adoption underscores the effectiveness of Aktana in facilitating meaningful connections and driving impactful engagement strategies.

ZONTAL stands out as a prominent provider of digital solutions tailored for the life sciences sector, focusing on optimizing laboratory workflows and speeding up research results through advanced analytics and data science. Their all-encompassing platform features a range of products aimed at improving data management, including the Digital Lab for connecting experts and data, Data Preservation for the protection of critical information, and the Life Science Analytics Platform for seamless integration of analytics into laboratory processes. By prioritizing data to be Findable, Accessible, Interoperable, and Reusable (FAIR), ZONTAL enables organizations to reduce the complexities of data handling, conduct real-time analyses, and tap into limitless analytical capabilities. This transformation not only enhances laboratory operations but also promotes innovation within the modern digital landscape, ensuring that organizations remain competitive and forward-thinking in their research endeavors.

The AssurX platform is a powerful software platform for enterprise quality management (EQMS) and regulatory compliance to reliably communicate and coordinate information, documentation, and activities. AssurX allows regulated businesses to quickly identify and control quality issues and risk exposure to avoid quality or noncompliance problems while improving workflow. AssurX QMS software is uniquely configurable to fit any established or dynamic business requirements. The system creates an electronic workflow of tasks, alerts, escalations, and approvals that can be automated to the desired level, mapping precisely to real-world operations. No other system is easier to deploy, configure, and modify. AssurX solutions integrate seamlessly to create a connected quality system. Solutions include audit management, corrective actions, training management, compliant management, document management, change control, risk management, EHS incident management, and more.

Facilitate connections between healthcare entities such as hospitals, clinics, health plans, and life sciences with app developers and health data partners to create innovative digital services based on FHIR APIs. Enhance both the efficiency and safety of transitions throughout the continuum of care, whether in-patient or out-patient. Offer personalized wellness and prevention strategies tailored to at-risk individuals, fostering proactive health management. Encourage collaboration among patients, healthcare providers, and physicians to effectively address chronic conditions, leading to better management outcomes. Focus on patient-centered digital services that prioritize user experience and safety, while minimizing risks during care transitions. Utilize an enterprise-grade platform capable of managing, securing, and scaling APIs that remain agnostic to FHIR servers. Seamlessly integrate healthcare data from various sources, including internal systems, external partners, or open-source FHIR-ready resources. By swiftly launching digital services like mobile applications, advance the vision of patient-centric healthcare and enhance data interoperability, ultimately improving healthcare delivery for all. This approach not only enhances patient engagement but also drives innovation across the healthcare landscape.

The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.

Datatrak International, Inc. is a software-as-a-service provider of enterprise cloud-based technologies for the life sciences industry. Datatrak's unified eClinical solution and related services improve efficiency and cost effectiveness for the clinical trial industry. Datatrak developed its multi-component, comprehensive solution using a single platform. This concept was expanded to include services delivery through Datatrak's Clinical and Consulting Services groups. The Company offers a complete range of software products that can be used to speed up the reporting of clinical research data to sponsors and regulators. This is faster than using loosely integrated technologies. Our goal is to empower workgroups with role-based access, version-controlled file management and calendar events, tasks, and contacts. All built within our eClinical software applications, including EDC, CTMS and reporting.

Tempus AI, a prominent health technology firm based in Chicago, Illinois, is dedicated to transforming patient care through advanced artificial intelligence and precision medicine. By utilizing data and AI, the company strives to create personalized treatment plans across a range of medical specialties, such as oncology, cardiology, radiology, and mental health. Their all-encompassing platform combines genomic sequencing, clinical data, and AI-powered analytics, equipping healthcare providers and researchers with actionable insights. Tempus offers a holistic understanding of patients via various testing methods, including tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline tests, as well as tumor-normal matched profiling and minimal residual disease monitoring options. Additionally, they provide a swift and dependable platform for ordering tests, gaining patient insights, and seamlessly integrating AI-driven technologies into practice. Furthermore, Tempus features an innovative generative AI-enabled clinical assistant that places patient insights readily at your fingertips, enhancing the overall efficiency of healthcare delivery. This commitment to leveraging cutting-edge technology exemplifies Tempus AI's mission to improve health outcomes and advance medical research.

The Life Sciences Cloud by Salesforce is an all-encompassing platform aimed at aiding pharmaceutical, biotech, and MedTech firms at every stage of the product lifecycle, from the initial clinical trials to the final commercialization phase. By leveraging AI-driven tools and insightful data, it enhances patient engagement, accelerates medical inquiry responses, optimizes clinical trial management, and boosts sales and marketing initiatives. The platform's features, including intelligent healthcare professional engagement, tailored patient services, and predictive analytics, enable organizations to create customized experiences, improve patient outcomes, and efficiently navigate complex regulatory environments. Additionally, its seamless integration with other Salesforce offerings and external tools ensures a comprehensive perspective of the healthcare landscape. This holistic approach facilitates collaboration and innovation among stakeholders within the healthcare industry.

Accounting, accruals and FP&A Software with real-time clinical data and collaboration between third-party vendors. Designed by biotech finance experts and audit professionals who have walked in your shoes. 1) Automate and accelerate clinical accruals. Stop manually updating spreadsheets and trackers. We use real data to drive accruals and save you time and money. 2) Hold vendors accountable. It can be difficult to trust vendors to provide accurate, timely and complete updates. Condor "audits", with documentation and proof, your vendors. Condor helps you improve your audits. We provide peace of mind in critical audit matters. 4) Empowering Cross-Functional Alignment - Build Trust and Shared Understanding between Clinical, Finance, and Third Parties with a Single Source of Truth. 5) Financial insights and scenario cash-planning - Help leaders make data-driven decision.

Introducing IDBS Polar, the pioneering BioPharma Lifecycle Management (BPLM) platform that streamlines tedious manual operations, empowering you to carry out processes more effectively while gathering the essential data needed to speed up market entry by addressing significant hurdles in process design, optimization, scale-up, and technology transfer. This innovative platform features interactive data analytics tools, including a bioreactor comparison tool tailored for biopharma development scientists. IDBS Polar excels at securely overseeing drug progression through comprehensive workflows, seamless integration, and insightful data analysis. Its structured workflows are crafted to ease the complexities of the BioPharma Lifecycle, ensuring process-aware planning, design, and execution of complete bioprocess and analytical unit operations. Meaningful integrations enhance the relevance of your data, while rapid incorporation into your development ecosystem fosters automation and establishes a robust, process-centric data framework. In an industry where precision and efficiency are paramount, IDBS Polar stands out as a vital solution for modern biopharmaceutical development.

X-Fly stands out as a premier insights management platform tailored specifically for medical affairs and life sciences teams, providing an easy-to-use interface that simplifies the capture, analysis, and sharing of essential insights. Users can conveniently collect data from any device or CRM, whether through unprompted free text or structured survey responses. The platform's interactive and automated reporting capabilities remove the complexities of traditional spreadsheets, allowing for efficient analysis and the identification of patterns and emerging trends. With its AI-driven copilot, X-Fly automates repetitive tasks, improves the quality of insights, and keeps track of new trends, thereby supporting data-informed decision-making. Designed to be both scalable and customizable, the platform serves the needs of small teams making the switch from Excel as well as large global organizations, all facilitated by a simple two-week implementation timeline. Moreover, X-Fly prioritizes robust security and compliance features to safeguard data privacy in every market, underpinned by detailed access controls. This commitment to security and usability makes it a versatile choice for organizations aiming to enhance their insights management processes.

Mednet is an eClinical technology company that specializes in healthcare solutions for the global life science community. Mednet's flexible, EDC-centric eClinical platform increases the efficiency of clinical research of all sizes. Mednet's comprehensive solution suite provides all the tools necessary to create and manage clinical research. It can also adapt to changing demands and requirements. Mednet has been trusted by CROs in every sector of the pharmaceutical, medical device, and biotechnology industries for almost 20 years. They provide the expertise, reliability, and innovation that they need to succeed. Mednetsolutions.com has more information.

ZAIDYN is a cutting-edge, cloud-based platform crafted by ZS aimed at transforming the life sciences sector. This innovative tool combines sophisticated analytics, machine learning capabilities, and smart workflows to help organizations streamline their processes in research and development, commercialization, and patient interaction. Designed with a modular approach, ZAIDYN offers scalable solutions that can be customized to meet diverse requirements, enabling smooth integration with current IT systems thanks to its open architecture. By delivering cohesive, high-quality data and insights, the platform fosters enhanced collaboration across different functions, which minimizes operational silos and encourages more informed decision-making. Prioritizing security and compliance, ZAIDYN upholds data privacy and meets regulatory standards, establishing itself as a trustworthy option for life sciences companies striving to innovate and elevate health outcomes. Ultimately, its comprehensive features provide organizations with the tools they need to navigate the complexities of the industry effectively.

Revolutionize your approach to managing bids and tenders by consolidating fragmented spreadsheets into a unified platform. With the CM | XS Suite, every step from the initial planning phase to ongoing oversight and governance is addressed, optimizing your return on investment for every tender through numerous pre-built features. The innovative eXtensibility concept introduces an array of options and functionalities within an integrated framework, ensuring that all stakeholders involved in the tendering process are aligned with the primary objectives and goals. This ready-to-use solution encompasses all the requirements that a tender office representative might have, serving as an essential managerial tool to oversee performance metrics, including compliance with contracts and long-term business growth. Keep track of your tender lifecycle in real-time, and leverage sophisticated analytical tools to uncover insights that will give you a competitive edge. Additionally, you can effortlessly create reports to monitor and analyze your company's bidding and tender activities, ensuring that you stay ahead in a dynamic marketplace. By centralizing these processes, you not only enhance efficiency but also foster collaboration among teams working on various tenders.

Acuity is an innovative platform powered by artificial intelligence, tailored for the healthcare and biopharma sectors, with a primary focus on discovering, profiling, and engaging Key Opinion Leaders (KOLs). Leveraging sophisticated analytics, Acuity extracts data from various sources, including digital interactions, conference attendance, scholarly publications, and other professional activities to develop comprehensive profiles of KOLs. The platform facilitates the segmentation and selection process of KOLs while also mapping their influence across different regions and monitoring their interactions. Additionally, it incorporates sentiment analysis that enables users to evaluate the impact of digital leaders on audiences through multiple channels, including social media and presentations. Acuity's customizable nature allows for seamless integration with customer relationship management systems such as Veeva or Salesforce. Furthermore, the platform provides tools for clinical trial profiling, assisting organizations in streamlining clinical trial recruitment by identifying leading trialists and enhancing their recruitment strategies. This multifaceted approach ensures that companies can effectively engage with influential figures in the industry.

An integrated platform that bridges scientific reasoning, compound development, and computational tools is now available. Chemaxon’s Design Hub supports medicinal chemistry by facilitating the analysis and prioritization of innovative ideas. This unified platform allows users to design compounds and manage concepts seamlessly. Transitioning from traditional PowerPoint presentations to dynamic, visually engaging, and chemically searchable hypotheses enhances the compound design workflow. Users can conveniently utilize established physicochemical properties, computational models, novelty considerations, or accessible compound catalogs within an interactive visual setting. Collaborate with your Contract Research Organizations (CROs) in the compound development journey through this secure online resource. Furthermore, assess the gathered data from biological assays or experimental structural insights to derive Structure-Activity Relationships (SAR) and generate fresh hypotheses for subsequent optimization cycles. Your scientific ideas can be conveniently organized in a “designer's electronic lab notebook,” which features chemically aware drawing tools that streamline the design process. This comprehensive approach ensures that every step of compound development is efficient and well-documented, paving the way for future innovations.

SANeForce serves as a robust solution for customer relationship management (CRM) and sales force automation (SFA), specifically designed for the pharmaceutical, healthcare, and life sciences sectors. Aimed at boosting the efficiency of sales and marketing teams, SANeForce provides functionalities such as real-time order management, tracking of expenses, inventory oversight, and territory management. Furthermore, the platform facilitates medical representative (MR) reporting, allowing field sales representatives to document visits, record doctor interactions, and schedule appointments straight from their mobile devices. By leveraging data-driven insights and analytics, organizations can monitor performance, streamline their operations, and enhance their customer engagement approaches. In addition to these capabilities, SANeForce incorporates compliance management features, ensuring it meets the stringent requirements of highly regulated industries that demand precise record-keeping. This makes it not only a practical choice for improving sales processes but also a dependable partner in maintaining industry standards and regulatory compliance.

Amazon Comprehend Medical is a natural language processing (NLP) service compliant with HIPAA that leverages machine learning to retrieve health information from medical texts without requiring any prior machine learning expertise. A significant portion of health data exists in unstructured formats such as physician notes, clinical trial documentation, and patient medical records. The traditional approach of manually extracting this data is labor-intensive and inefficient, while automated methods based on strict rules often overlook crucial contextual details, leading to incomplete data capture. Consequently, this limitation results in valuable information remaining untapped for large-scale analytical efforts that are essential for progressing the healthcare and life sciences sectors, ultimately impacting patient care and operational efficiencies. By addressing these challenges, Amazon Comprehend Medical enables healthcare professionals to harness their data more effectively for better decision-making and innovation.

OmicsBox, a leading bioinformatics tool, offers end-toend data analysis for genomes, transcriptomes and metagenomes. It also provides genetic variation studies. The application, which is used by leading private and public research institutes worldwide, allows researchers to process large and complicated data sets and streamline their analytical process. It is designed to be efficient, user-friendly and equipped with powerful tools to extract biological insight from omics data. The software is divided into modules, each of which has a set of tools and features designed to perform specific types of analyses, such as de novo genome assemblies, genetic variations analysis, differential expression analyses, taxonomic classifications, and taxonomic classes of microbiome, including the interpretation of results and rich visualizations. The functional analysis module uses the popular Blast2GO annotating methodology, making OmicsBox a great tool for non-model organisms research.

QliqCHAT Secure Texting is a real-time, secure, HIPAA-compliant healthcare communication platform that connects every care team member and facilitates effective, patient-focused collaboration. Securely bridge the communication and collaboration gap between doctors, nurses, patients, and caregivers. QliqSOFT is the developer of multimodal healthcare communication and automation platforms that harmonize people and technology across physical and online points of care. The intuitive, customizable platform streamlines administrative processes and enhances patient engagement by incorporating seamless EHR integration, conversational artificial intelligence (AI), and translation services. For more than a decade, QliqSOFT has helped healthcare organizations facilitate HIPAA-compliant, real-time communication exchange among healthcare practitioners and patients while automating routine clinical processes that bring immediate relief to overburdened employees while changing the way they work. QliqSOFT solutions assist over 1,000 healthcare organizations in realizing qualitative returns on their investment.